US FDA approves Eyenovia's eye drug, Formosa Pharma says
04/03/2024 23:06
March 4 (Reuters) - The U.S. Food and Drug
Administration approved Eyenovia's EYEN.O eye drops to reduce
inflammation and pain in patients who have undergone eye
surgery, Formosa Pharmaceuticals 6838.TWO said on Monday.
Eyenovia acquired U.S. commercial rights of the drug in
August last year from Formosa Pharmaceuticals.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak
Dasgupta)
((Sriparna.Roy@thomsonreuters.com))
Recent news on Formosa Pharmaceuticals
See all newsBrief: Formosa Pharmaceuticals Announces Licensing Agreement With Rxilient
Brief: Harrow Acquires U.S. Commercial Rights To Byqlovi™ From Formosa Pharmaceuticals
US FDA approves Eyenovia's eye drug, Formosa Pharma says (updated)
US FDA approves Eyenovia's eye drug, Formosa Pharma says
Brief: Formosa Pharmaceuticals And Aimmax Therapeutics Receive FDA Approval For Clobetasol Propionate Ophthalmic Suspension 0.05%